Gerhard Levy Endowment Fund

Two students examining a vial.

The Department of Pharmaceutical Sciences uses this fund to support scholarships for outstanding graduate students as well as the Levy Lecture.

Dr. Gerhard Levy is considered the father of pharmacodynamics for his role as a pioneer and principal contributor in the fields of biopharmaceutics, pharmacokinetics, clinical pharmacokinetics and pharmacodynamics.

This fund enables the Department of Pharmaceutical Sciences to provide for Levy Graduate Scholarships as well as the Gerhard Levy Distinguished Lectureship. The fund was established in 1999 by various donors.

Dr. Levy was a UB faculty member from 1959 until he retired in 2000. Throughout his distinguished career, he served on several editorial boards, wrote many articles and received honorary doctorates from six universities.

Dr. Levy received numerous awards, including the first Lifetime Achievement in the Pharmaceutical Sciences Award from the International Pharmaceutical Federation; the Medeval Distinguished Lecturer in Pharmaceutical Sciences from the University of Manchester, England; and the Distinguished Investigator Award from the American College of Clinical Pharmacology.

Make a Difference Now

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • UB SPPS showcases research and scholarship at 2023 ACCP Annual Meeting
    12/6/23
    Faculty, residents, fellows and students from the University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences (SPPS) attended the American College of Clinical Pharmacy (ACCP) Annual Meeting in Dallas, TX, from November 11-14 to showcase our school’s research and scholarship with the national clinical pharmacy community.
  • UB CIGBS Announces Stop Diabetes Progression, a New Global Community Health Site Initiative
    10/18/23
    The University at Buffalo (UB) Center for Integrated Global Biomedical Sciences (CIGBS) has announced plans to launch, Stop Diabetes Progression, a new health initiative, focusing on the creation of community-based education networks in Western New York, Jamaica and Zimbabwe to engage individuals with pre-diabetes and those with an established diagnosis of diabetes mellitus. The goal of this new initiative is to stop the progression of the disease for both groups.
  • UB Center for Integrated Global Biomedical Sciences selected to host Zimbabwe Emerging Faculty Development Program
    5/18/23
    The University at Buffalo, State University of New York (UB SUNY) has been selected to be the United States host for the Zimbabwe Emerging Faculty Development Program (ZEFDP). Through a grant funded by the U.S. Department of State to the Institute of International Education, a global non-profit organization facilitating international exchange, the program will bring nine faculty from different universities in Zimbabwe to UB for six weeks beginning in early June 2023. The programmatic areas include biomedical research, pharmacy, university administration, public health, and sustainable development. 
  • UB SPPS showcases educational and intellectual innovation at AACP Annual Meeting
    8/7/23
    Faculty and staff from the University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences (SPPS) attended the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Aurora, CO, from July 22-25 to share our school’s cutting-edge research and educational innovation with the national pharmacy academic community.
  • Anadi named inaugural UB SPPS PAL Fellow
    6/16/23
    Ijeoma (EJ) Anadi, PharmD ’23, MS ’22, has been named the inaugural fellow for the UB School of Pharmacy and Pharmaceutical Sciences (SPPS) Pharmacy Academic and Leadership (PAL) Fellowship program. 
  • Woo selected for NIH Drug Discovery and Molecular Pharmacology Study Section
    9/11/23
    The National Institutes of Health (NIH) Center for Scientific Review has appointed Sukyung Woo, PhD, associate professor, Department of Pharmaceutical Sciences, to serve as a member of its Drug Discovery and Molecular Pharmacology C (DMPC) Study Section.
  • Mark J. Sinnett BS ’83, PharmD ’87: 2023 UB Distinguished Alumni Award
    8/1/23
    BUFFALO, N.Y. — Mark J. Sinnett BS ’83, PharmD ’87 is a recipient of a 2023 University at Buffalo Distinguished Alumni Award. This award is given to alumni who have made a significant impact on the university at-large and also to the programs and students at the UB School of Pharmacy and Pharmaceutical Sciences (SPPS).